DAKLINZA
- Product NDC
- 0003-0011
- 11-digit product format
- 000030011
- Labeler code
- 0003
- Product ID
- 0003-0011_780ae42b-9b05-4a02-9529-5e45dbb460f6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- daclatasvir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Application
- NDA206843
- Marketing category
- NDA
- Marketing start
- 2016-05-18
- Marketing end
- 2019-04-30
- Substance
- DACLATASVIR DIHYDROCHLORIDE
- Active strength
- 90 mg/1
- Pharmacologic classes
- Hepatitis C Virus NS5A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record